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Abstract
Background: Arsenic is well-established as a human carcinogen, but the molecular mechanisms leading to arsenic-induced
carcinogenesis are complex and elusive. It is not been determined if the epithelial-mesenchymal transition (EMT) and stem
cell-like properties contribute in causing to carcinogen-induced malignant transformation and subsequent tumor formation.
Methods: To investigate the molecular mechanisms underlying EMT and the emergence of cancer stem cell-like properties
during neoplastic transformation of human bronchial epithelial (HBE) cells induced by chronic exposure to arsenite. HBE
cells were continuously exposed to arsenite. Spheroid formation assays and analyses of side populations (SPs) were
performed to confirm that arsenite induces the acquired EMT and cancer stem cell-like phenotype. Treated HBE cells were
molecularly characterized by RT-PCR, Western blots, immunofluorescence, Southwestern assays, reporter assays, and
chromatin immunoprecipitation.
Results: With chronic exposure to arsenite, HBE cells undergo an EMT and then acquire a malignant cancer stem cell-like
phenotype. Twist1 and Bmi1 are involved in arsenite-induced EMT. The process is directly regulated by HIF-2a. The self-
renewal genes, Oct4, Bmi1, and ALDH1, are necessary for arsenite-mediated maintenance of stem cells.
Conclusions: EMT, regulated by HIF-2a, and the development of a cancer stem cell-like phenotype are associated with
arsenite-induced transformation of HBE cells.
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Introduction
The epithelial-mesenchymal transition (EMT) is a developmen-
tal process by which epithelial cells are converted to mesenchymal
cells during embryogenesis [1]. EMT, which involves loss of cell
polarity, decreases in cell-to-cell adhesion, and increased capacity
for migration, is necessary for tumor metastasis and organ fibrosis
[2]. EMT, however, has not been considered to be involved in
transformation of normal cells to malignant cells in the initiation of
tumorigenesis [3].
A concept recently proposed to explain the characteristics of
neoplastic tissues is the existence of self-renewing, stem-like cells
within tumors, which have been called cancer stem cells (CSCs)
[4]. Within a tumor, CSCs, which constitute a small portion of
neoplastic cells, are defined by their capacity to produce new
tumors. For this reason, they have also been termed ‘tumor-
initiating cells’ [5]. The process of EMT generates cells with stem-
like properties [6]. The link between EMT and induction of
cancer stem cells may explain why EMT induces tumor initiation
and progression.
Arsenic is well-established as a human carcinogen [7]. A positive
correlation exists between arsenic exposure and increased
incidences of various forms of cancer, as documented by reports
from arsenic-endemic areas of the world [8]. To deal with this
problem, it is essential to elucidate molecular mechanism involved
in arsenic-induced carcinogenesis.
Exposure to arsenic disrupts the dynamics of stem cells (SCs) in
human and rodent skin in vivo and in vitro, resulting in an
overabundance of stem cells/CSCs [9,10], an event likely involved
in development of skin cancer. Arsenite apparently transforms
prostate epithelial stem/progenitor cells into cancer stem-like cells
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37765that drive oncogenesis [11]. Arsenic affects human stem cells by
blocking differentiation pathways, which are considered to be
targets in carcinogenesis [12,13]. Chronic exposure to arsenite
triggers expression of the EMT-inducing transcription factors,
ZEB1 and ZEB2, resulting in EMT and malignant transformation
[14]. The induction of EMT is associated with acquisition of stem
cell-like features during malignant transformation induced by
other carcinogens [3]. It has not been determined, however, if, in
human cells, EMT and stem cell-like properties contributes in
causing to arsenite-induced malignant transformation and subse-
quent tumor formation.
In this study, we investigated the effect of chronic arsenic
exposure on the induction of EMT and the acquisition of stem
cell-like properties in human bronchial epithelial (HBE) cells. The
goal was to determine if arsenite-induced induction of EMT and
acquisition of stem cell-like properties are mechanisms associated
with arsenic-induced carcinogenesis. We report, for the first time,
a link between arsenite exposure, induction of EMT, and the
development of a stem cell-like phenotype that together may be
associated with malignant transformation and tumor formation.
Such information contributes to an understanding of lung
oncogenesis caused by arsenite.
Results
Chronic arsenite exposure causes EMT of HBE cells
A low concentration (1.0 mM) of arsenite increased the
neoplastic transformation of HBE cells, as determined by
anchorage-independent growth in soft agar and tumorigenesis in
nude mice (Figure S1). For HBE cells, alteration from epithelial to
spindle-like mesenchymal morphology is a manifestation of
arsenite-induced transformation. This change indicates that
chronic arsenite exposure causes EMT of HBE cells. To test the
hypothesis, HBE cells were exposed to 0.0 or 1.0 mM arsenite for
15 weeks. The alterations from epithelial to spindle-like mesen-
chymal morphology started at 10 weeks of arsenite exposure and
increased thereafter; the cells acquired a fibroblast-like mesenchy-
mal appearance consistent with EMT with increased time of
exposure (Figure 1A).
The expression of the EMT markers, E-cadherin, N-cadherin,
and vimentin, was determined [15]. After 5 weeks of arsenite
exposure, expression of the epithelial marker, E-cadherin,
decreased. In contrast, expression of the mesenchymal marker,
vimentin, increased with longer times of arsenite exposure
(Figures 1B, 1C, 1D and 1E). To determine if the molecular
alterations of EMT occurred in control and transformed HBE
cells, staining of E-cadherin and vimentin, measured by immuno-
fluorescence microscopy, confirmed the EMT-associated shift in
the localization of markers. The transformed cells formed
epithelial-like intercellular junctions and displayed increased
expression of fibroblast markers (Figure 1D). Hence, both
morphological and molecular changes demonstrated that, with
chronic exposure to arsenite, HBE cells underwent an EMT.
Twist1 is involved in arsenite-induced EMT of HBE cells
The process of EMT is controlled by transcriptional factors,
including the zinc finger proteins, Snail, Slug, ZEB1, and ZEB2/
SIP1, and the basic helix-loop-helix factor, Twist1 [16]. The EMT
regulators, ZEB1 and ZEB2, are active in cells chronically exposed
to arsenite [14]. The expressions of ZEB1, ZEB2, Snail1, Slug, and
Twist1 in control and arsenite-transformed HBE cells were
determined. Expression of Twist1 increased with longer times of
arsenite exposure, and ZEB1 and ZEB2 expressions were increased
startingfromabout10weeksofchronicarseniteexposure(Figures2A
and 2B). To determine if arsenite induces ZEB1, ZEB2, and Twist1
expressions, HBE cells were treated with 0.0 or 1.0 mM of arsenite
for 0, 6, 12, or 24 h. In arsenite-treated HBE cells, only the levels of
Twist1 increased. ZEB1 and ZEB2 expressions were not changed,
and the levels of Snail and Slug were not appreciably altered
(Figures 2C and 2D). These results suggest that up-regulation of
Twist1 is associated with arsenite-induced EMT.
HBE cells acquire stem cell-like properties during
arsenite-induced EMT
Since induction of EMT has been associated with the
acquisition of stem cell-like features, including nonadherent
growth and changes in expression of cell-surface glycoproteins
[17], the capacity of HBE cells for formation of spheroids during
arsenite-induced EMT was determined. Formation of spheroids
demonstrates the capacity of cells for self-renewal and for initiation
of tumors [18], which are characteristics of stem cells. In arsenite-
induced EMT of HBE cells, there was an increase in formation of
spheroids (Figure 3A).
To test the self-renewal capacity of the sphere-forming cells, the
primary spheroids were dissociated into single cells, and secondary
spheroid assays were performed [18]. The number of secondary
spheroids was greater than for primary spheroids (Figure 3B).
CD133 and CD44 are cell-surface markers of lung stem cells
[19,20]. During the arsenite-induced EMT of HBE cells, there
were increased levels of mRNAs for CD133 and CD44 (Figures 3C
and 3D). SP cells, which are enriched along with stem cells,
provide an alternative source for markers that is particularly useful
in situations where molecular markers for stem cells are unknown
[21]. Flow cytometric analysis indicated that the percentage of SP
cells increased in the arsenite-induced EMT of HBE cells
(Figure 3E). These data demonstrate that HBE cells acquire stem
cell-like characteristics by chronic exposure to arsenite.
Self-renewal genes are over-expressed during arsenite-
induced acquisition of the stem cells-like phenotype
The expression of self-renewal genes during arsenite-induced
acquisition of the stem-cell like phenotype was examined. In CSCs
from various cancers, there is expression of the key ‘stemness’
genes, Oct-4, Bmi1, Notch1, ALDH1, and Sox2 [22,23,24]. As
determined in the present study, with longer time of exposure to
arsenite, there was increased expression of mRNAs for Oct4, Bmi1,
and ALDH1; however, there were no substantial changes in
expressions of mRNAs for Notch and Sox2 (Figures 4A–4E). These
results indicate that the self-renewal genes, Oct4, Bmi1, and ALDH1
are necessary for arsenite-mediated maintenance of stem cells.
Bmi1 is involved in arsenite-induced acquisition of stem
cell-like properties in HBE cells
Of the self-renewal genes necessary for arsenite-mediated
maintenance of stem cells, Bmi1 has been reported to be causal
for the transformation of cells [25]. However, the function of Bmi1
in arsenite-induced transformation remains unknown. Based on our
results and others, the function of Bmi1 in arsenite-treated cells was
investigated. In HBE cells chronically exposed to arsenite, the levels
of Bmi1increased with increased weeks of exposure (Figures 5A and
5B). Moreover, the levels of Bmi1 increased in cells exposed to
arsenite for 6, 12, or 24 h (Figures 5C and 5D).
In arsenite-induced EMT, HIF-2a regulates the levels of
Twist1 and Bmi1 and the stem-like properties of HBE cells
In stem cells, HIF proteins maintain an undifferentiated state
and are essential regulators for EMT [26]. The present results
EMT/CSCs Are Involved in Chemical Carcinogenesis
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37765Figure 1. Chronic exposure to arsenite induces EMT in HBE cells. Abbreviations: E-cad, E-cadherin; N-cad, N-cadherin; Vim, vimentin.
Densities of bands were quantified by Eagle Eye II software. GAPDH levels, measured in parallel, served as controls. HBE cells were exposed to 0.0 or
1.0 mM arsenite for 0, 5, 10 or 15 weeks. (A) Morphology of HBE cells during arsenite treatment for 0, 5, 10, and 15 weeks; bars=250 mm, or
bars=100 mm. The mRNA levels of E-cadherin, N-cadherin, and vimentin were determined by RT-PCR (B) and by quantitative RT-PCR (C, means 6 SD,
n=3) after HBE cells were exposed to 0.0 or 1.0 mM arsenite for 0, 5, 10 or 15 weeks.
*P,0.05 difference from control HBE cells. Western blots (D) and
relative protein levels (E, means 6 SD, n=3) of E-cadherin, N-cadherin, and vimentin in HBE cells exposed to arsenite for 0, 5, 10, or 15 weeks. (F)
Immuofluorescence staining of E-cadherin and vimentin in HBE cells for the indicated times. Red represents E-cadherin and vimentin staining. Blue
represents nuclear DNA staining by DAPI; bars=25 mm.
doi:10.1371/journal.pone.0037765.g001
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tion of HIF-2a by inhibiting the ubiquitin-proteasome pathway
under normoxic conditions (Figure S2). As determined by reporter
assays, the HIF-2a-dependent transcriptional activity in HBE cells
is activated by arsenite, and Twist1-Luc and Bmi1-Luc respond to
arsenite stimulation (Figure 6A), suggesting that HIF-2a regulates
Twist1 and Bmi1 expression by directly binding to its promoter.
Since the DNA sequence (GGGCGGCGCGTGTGGCGCTG) of
the Bmi1, and (GTGTGTGCGCGTGAGTGTGCGTGACAG-
GAG) of the Twist1 promoters contain an hypoxia-responsive
element [HRE, (A/G)CGTG], Southwestern and Western blots
were used to determine if HIF-2a induces Bmi1 and Twist1
directly. The results revealed a band with a molecular weight of
,120 kDa. The protein was identified as HIF-2a by incubation of
the membrane obtained by Southwestern analysis with anti-HIF-
2a antibody (Figure 6B and 6C). It is possible that the increases in
Bmi1 and Twist1 were induced by activation of HIF-2a.T o
further examine the binding of HIF-2a to the Bmi1 and Twist1
promoter, a chromatin immunoprecipitation (ChIP) assay was
performed. Upon arsenite exposure, HIF-2a bound to the Bmi1
and Twist1 gene promoters. In contrast, IgG did not associate with
the Bmi1and Twist1 promoters at a detectable level (Figure 6D).
HIF-2a knockdown abolished the increases of Twist1 and Bmi1
expression induced by arsenite (Figure 6E), suggesting that HIF-2a
directly regulates Twist1 and Bmi1 in arsenite-induced EMT and
the stem-like properties of HBE cells.
Discussion
Inorganic arsenic is a widely distributed, naturally occurring
environmental contaminant affecting tens of millions of people
worldwide [27]. Chronic exposure to arsenic causes carcinogenesis
of lung, skin, and bladder [28,29]. Although there is evidence for
the lung carcinogenicity of inorganic arsenic compounds in
humans, the molecular mechanisms remain incompletely defined.
EMT refers to a program during normal embryonic develop-
ment featuring a loss of epithelial properties, such as cell adhesion
and expression of the epithelial marker, E-cadherin, and
acquisition of mesenchymal properties, such as increased cell
motility and expression of the mesenchymal marker, vimentin [1].
EMT, which is viewed as an important step in tumor invasion and
metastasis [15], has not, however, been regarded as involved in
malignant transformation of normal cells, that is, the initiation of
tumorigenesis. The exposure of cells to arsenite or tobacco
carcinogens induces EMT during transformation and tumor
formation [3,14], suggesting that the regulation of EMT
morphology, induction of a stem cell-like phenotype, and
transformation are distinct events in response to carcinogen
Figure 2. Twist1 is involved in arsenite-induced EMT in HBE cells. Densities of bands were quantified by Eagle Eye II software. GAPDH levels,
measured in parallel, served as controls. HBE cells were exposed to 0.0 or 1.0 mM arsenite for 5, 10 or 15 weeks. Western blots (A) and relative protein
levels (B, means 6 SD, n=3) of ZEB1, ZEB2, Twist1, Snail, and Slug were determined in control and treated HBE cells at the indicated times. Western
blots (C) were performed and relative protein levels (D, means 6 SD, n=3) of ZEB1, ZEB2, Twist1, Snail and Slug were measured after HBE cells were
exposed to 0.0 or 1.0 mM arsenite for 0, 6, 12, or 24 h.
doi:10.1371/journal.pone.0037765.g002
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e37765Figure 3. Arsenite-induced EMT of HBE cells causes them to acquire stem cell–like properties. HBE cells were exposed to 0.0 or 1.0 mM
arsenite for 15 weeks. (A) Phase-contrast images of the primary spheroids that were seeded by control HBE cells, untreated cells, and cells treated
with arsenite for 15 weeks. (B) The primary spheroids were dissociated into single cells and cultured for secondary spheroids; the primary and
secondary spheroids formed were quantified (means 6 SD, n=3); bars=25 mm, or bars=100 mm,
*P,0.05 difference from control cells. The mRNA
level of CD44 and CD133 were determined by RT-PCR (C) and by quantitative RT-PCR (D, means 6 SD, n=3) after HBE cells were exposed to 0.0 or
1.0 mM arsenite for 0, 5, 10 or 15 weeks.
*P,0.05 difference from control HBE cells. (E) Control cells, untreated cells, and HBE cells treated with arsenite
for 15 weeks were fixed, and SP cells were analyzed by FACS. (F) The percentages of SP cells in the gated area are shown for cells.
*P,0.05 different
from control HBE cells.
doi:10.1371/journal.pone.0037765.g003
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the EMT in HBE cells. Thus, arsenite-induced EMT of HBE cells
is associated with transformation.
The process of EMT is controlled by transcriptional factors,
including the zinc finger proteins, Snail, Slug, ZEB1, and ZEB2/
SIP1, as well as the basic helix-loop-helix factor, Twist1. These
transcriptional factors have been implicated in the transcriptional
repression of E-cadherin in the induction of EMT [16]. In cells
chronically exposed to arsenite, the EMT regulators, ZEB1 and
ZEB2, are repressors of expression of E-cadherin, thus resulting in
EMT [14]. Other regulators, however, have not been considered
to be involved in arsenite induced-EMT. In the present study,
which involved comparison of ZEB1, ZEB2, Slug, Snail, and
Twist1 in control and arsenite-exposed cells, there was differential
induction of these EMT regulators. Twist1 was induced by
arsenite exposure, but Snail and Slug were not appreciably altered.
ZEB1 and ZEB2 expressions were detected only in arsenite
chronic-exposed cells, but there were no changes in cells acutely-
exposed to arsenite. This was also observed by Wang et al. [14].
Therefore, we concluded that Twist1 is involved in the process of
arsenite induced-EMT, but ZEB1and ZEB2 are involved only in
the later period of arsenite-induced EMT. These results suggest
that, along with ZEB1 and ZEB2, Twist1 is a novel transcription
factor that is involved in arsenite-induced EMT.
The morphologic heterogeneity of lung tumors suggests that
EMT is a process that drives differentiation and dedifferentiation
Figure 4. Oct4, Bmi1, and ALDH1 are over-expressed during arsenite-induced acquisition of the stem cell-like phenotype. HBE cells
were exposed to 0.0 or 1.0 mM arsenite for 5, 10, or 15 weeks. (A) The mRNA levels of Oct4, Bmi1, ALDH1, Notch1, and Sox2 were determined by RT-
PCR. Quantitative RT-PCR (means 6 SD, n=3) was used to measure the transcript level of Oct4 (B), Bmi1 (C), ALDH1 (D), Notch1 (E), and Sox2 (F) after
HBE cells were exposed to 0.0 or 1.0 mM arsenite for the indicated times.
*P,0.05 difference from control cells.
doi:10.1371/journal.pone.0037765.g004
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mammary epithelial cells into the EMT phenotype was concom-
itant with the acquisition of the CD44
high/CD24
low expression
pattern and increased mammosphere-forming and tumor-initiat-
ing capacity [6,31]. A recent investigation found that the induction
of EMT resulted in an increased population of CD44
high/CD24
low
cells and drug resistance associated with CSC signatures [32].
These reports suggest that cells with an EMT phenotype, induced
by different factors, are rich sources for CSCs.
Stem cells are probably a key target in arsenic carcinogenesis.
Arsenic induces malignant transformation of stem cells in vitro [11]
and causes an overproduction of CSCs that is associated with an
acquired malignant phenotype or cancer production [10,13]. In
the present study, cells exposed to arsenite for induction of EMT
exhibited enhanced capacity for forming mammospheres and
CSCs, compared to control cells. Expressions of CD133 and
CD44 were substantially increased in the arsenite-induced EMT.
SPs of cells, which are enriched in primitive and undifferenti-
ated CSCs, are long-lived, self-renewing, and highly proliferative
[33]. In the present investigation, the percentage of SP cells
increased in the arsenite-induced EMT of HBE cells. These results
indicate that arsenite converts normal cells to CSCs.
Stem cells and CSCs share a variety of properties, including self-
renewal, although it is typically dysregulated in CSCs [34]. In
embryonic stem cells, embryonic epiblasts, and primordial germ
cells, Oct4 is essential for maintaining an undifferentiated state,
[22]. In several types of stem cells, Bmi-1 is implicated in the
modulation of self-renewal [34,35]. For several cell types, the
Notch pathway controls the fate of stem cells [34], and, for
humans, ALDH1 is a marker of normal and malignant mammary
stem cells [23]. Sox2 is a transcription factor essential for the
pluripotent and self-renewing phenotypes of CSCs [24]. The
expressions of Oct4, Bmi1, and ALDH1 are involved in maintaining
cancer stem-like cells in lung cancer. They also have a role in
epithelial tumorigenesis and provide a molecular link between
putative lung stem cells and lung tumorigenesis [36,37,38,39]. The
present study shows that there is up-regulation of expressions of
Oct4, Bmi1 and ALDH1 in chronic exposure to arsenite. This
observation is consistent with the concept that the self-renewal
genes, Oct4, Bmi1, and ALDH1 are necessary for arsenite-mediated
maintenance of cancer stem-like cells.
In the present study, we found that arsenite produces CSCs
during malignant transformation of HBE cells, and, during this
process, the HBE cells acquire a fibroblast-like mesenchymal
appearance consistent with EMT. However, the process of EMT is
unlikely to be involved in acquisition of stem cell-like features.
Arsenite-induced EMT and the acquisition of stem cell-like
features may be associated with arsenite-induced malignant
transformation. Further studies are needed to elucidate the
Figure 5. Bmi1 is involved in arsenite-induced acquisition of stem cell-like properties in HBE cells. Densities of bands were quantified by
Eagle Eye II software. GAPDH levels, measured in parallel, served as controls. HBE cells were exposed to 0.0 or 1.0 mM arsenite for 5, 10, or 15 weeks.
Western blots (A) and relative protein levels (B, means 6 SD, n=3) of Bmi1 were determined in control and treated HBE cells at the indicated times.
Western blots (C) were performed and relative protein levels (D, means 6 SD, n=3) of Bmi1 were measured after HBE cells were exposed to 0.0 or
1.0 mM arsenite for 0, 6, 12, or 24 h.
doi:10.1371/journal.pone.0037765.g005
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treatment or induction of EMT.
Hypoxia-inducible factors (HIFs) maintain an undifferentiated
state in stem cells [40]. In particular, Oct4 is a target gene for HIF-
2a, indicating that HIF-2a regulates stem cell function and/or
differentiation through activation of Oct4 [41]. Additionally, HIF-
2a could induce EMT through transcription of EMT regulators
[42]. Hence, based on these findings, HIF-2a may be necessary for
arsenite-mediated induction of EMT and for maintenance of
cancer stem-like cells. Apparently, HIF-2a could regulate Twist1
in cells undergoing an EMT, and Bmi1 is essential for Twist1-
induced EMT and tumor-initiating capacity [43], we found that
Figure 6. HIF-2a regulates Bmi1 and Twist1 in arsenite-induced EMT and acquisition of stem cell-like properties. (A) Schematic
representation of the regulatory region of the Bmi1 and Twist1genes and reporter constructs used in transfection assays. The luciferase reporter
constructs were made with HRE, the Bmi1 regulatory region (Bmi1–Luc), or the Twist1 regulatory region (Twist1-Luc). HBE cells were co-transfected
with a promoter construct and the indicated vector in control and arsenite-treated HBE cells for 24 h. Luciferase activity was measured and
normalized according to Renilla luciferase activity (means 6 SD, n=3);
*P,0.05 different from control cells. HBE cells were incubated with 0.0 or
1.0 mM arsenite for 24 h. (B) A band of about 120-kDa interacts with the probe of Bmi1 (SW). The HIF-2a antibody was incubated with the same
membrane, and a 120-kDa band was identified (W). (C) The band of about 120-kDa interacts with the probe of Twist1 (SW). The HIF-2a antibody was
incubated with the same membrane, and a 120-kDa band was also identified (W). (D) After the chromatin was immunoprecipitated using antibodies
against HIF-2a, the binding of HIF-2a to promoters of Bmi1 and Twist1 were measured by a ChIP assay. (E) After HBE cells were exposed to 20 nM of
control siRNA or to 10 nM HIF-2a siRNA for 24 h, they were incubated with 0.0 or 1.0 mM arsenite for 24 h. Western blots of HIF-2a, Twist1, and Bmi1
were performed.
doi:10.1371/journal.pone.0037765.g006
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37765HIF-2a regulates Bmi1 and Twist1 transcription by directly
binding to their promoters under arsenite exposure.
The present study focused on the induction and function of
Bmi1 and Twist1 in cells chronically exposed to arsenite.
Nevertheless, other self-renewal genes, such as ALDH1, may be
necessary for arsenite-mediated maintenance of cancer stem-like
cells. Thus, further study is required to determine if higher
expression and function this gene is necessary for arsenite-
mediated maintenance of cancer stem-like cells.
We first reported that, during arsenite exposure, HIF-2a
directly induces Bmi1 expression through binding to HREs in
their promotor region, not by mediation of twist1 [43]. These
results provide support for an essential function of HIF-2a in
arsenite-mediated induction of EMT and in maintenance of
cancer stem-like cells.
In conclusion, this investigation expands our understanding of
the carcinogenic potential of arsenite by indicating that it can
targets CSCs for carcinogenic transformation. Arsenite-induced
oncogenic changes associated with HIF-2a are induction of EMT
and the development of a cancer stem cell-like phenotype during
malignant transformation. These observations contribute to a
better understanding of the processes involved in arsenite-induced
carcinogenesis.
Materials and Methods
Cell culture and reagents
HBE cells, a SV40-transformed normal human bronchial
epithelial cell line, are nontumorigenic and retain features of
human bronchial epithelial cells; they are useful for studies of
multistage bronchial epithelial carcinogenesis [44]. This cell line
was obtained from the Shanghai Institute of Cell Biology, Chinese
Academy of Sciences (Shanghai, China). HBE cells were
maintained in 5% CO2 at 37uC in Minimum Essential Medium
Eagle’s medium (MEM), supplemented with 10% fetal bovine
serum (FBS, Life Technologies/Gibco, Grand Island, NY),
100 U/ml penicillin, and 100 mg/ml streptomycin (Life Technol-
ogies/Gibco, Gaithersburg, MD). For chronic exposure, 1610
6
cells were seeded into 10-cm (diameter) dishes for 24 h and
maintained in 0.0 or 1.0 mM sodium arsenite (NaAsO2, Sigma, St.
Louis, MO, purity: 99.0%) for 48–72 h per passage. This process
was continued for about 15 weeks. All other reagents used were of
analytical grade or highest grade available.
Western blots
Total cell lysates were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and were trans-
ferred to polyvinylidene fluoride membranes (Millipore, Billerica,
MA, USA); the immune complexes were detected by enhanced
chemiluminescence (Cell Signaling Technology, Beverly, MA).
Antibodies used were: Twist1, Bmi1 and glyceraldehyde 3-
phosphate dehydrogenase (GAPDH, Sigma); hypoxia-inducible
factor-2a (HIF-2a, Novus, Littleton, CO); E-cadherin, N-cad-
herin, vimentin, Snail, Slug, ZEB1, and ZEB2 (Cell Signaling
Technology). Blots were quantitated by densitometry and
normalized using GAPDH to correct for differences in protein
loading. For densitometric analyses, protein bands on the blot
were measured by use of Eagle Eye II software.
RNA interference
The transfections were performed on HBE cells with the N-
TER
TM Nanoparticle siRNA Transfection System (Sigma) follow-
ing the manufacturer’s protocol. Briefly, 5610
5 cells were seeded
into each well of 6-well plates, 18–24 h prior to transfection. The
siRNA nanoparticle formation solution (NFS) was prepared by
adding target gene siRNA dilutions to N-TER peptide dilutions and
incubated at room temperature for 30 min. NFS transfection
medium (2 mL) containing target gene siRNA was transferred to
each well of the culture plates, and, after for 24 h, cells were treated
and harvested for analysis. Control siRNA was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). HIF-2a siRNA was
purchased form Abnova Corporation (Abnova, CA).
Quantitative real-time PCR
Total RNA was extracted, and RT-PCR was performed as
described previously [45]. Total RNA (2 mg) was transcribed into
cDNA by use of AMV Reverse Transcriptase (Promega, Madison,
Wisconsin, USA). Primers used are listed (Table S1). Quantitative
real-time PCR was performed using the Applied Biosystems
7300HT machine and Maxima
TM SYBR Green/ROX qPCR
Master Mix (Fermentas, USA). The PCR reaction was evaluated
by melting curve analysis and by checking the PCR products on
2% w/v agarose gels. GAPDH was amplified to ensure cDNA
integrity and to normalize expression.
Southwestern assays
Southwestern analyses were performed as described previously
[46]. Briefly, nuclear extracts (80 mg) of HBE cells were separated
by SDS-PAGE and transferred to nitrocellulose membranes
(Millipore). After transferring, the filters were hybridized for 2 h
at 20uC with binding buffer containing 40 ng of the biotin-labeled
probe for the promoter of Bmi1:
GGGCGGCGCGTGTGGCGCTG, and the promoter of
Twist1: GTGTGTGCGCGTGAGTGTGCGTGACAGGAG.
The filters were then washed in binding buffer at 20uC for
20 min. The positions of the biotin end-labeled oligonucleotides
were detected by a chemiluminescent reaction according to the
manufacturer’s instructions (Pierce, Rockford, IL) and visualized
by autoradiography.
Transient Transfection and Luciferase Activity Assay
The pGL3-HRE-Luc construct, pGL3-Bmi1-Luc construct,
and the pGL3-Twist1-Luc construct were purchased from
Shuntian Biology (Shanghai). The plasmid phRL-tk (used as
internal control for transfection efficiency and cytotoxicity of test
chemicals) containing the Renilla luciferase gene was purchased
from Promega (Madison, WI, USA). HBE cells (2610
6) were
plated in 100-mm cell culture dishes. The cells proliferated to 60 to
80% confluence after 24 h of culture. Then, 3 mg of DNA of the
reporter constructs was transfected into cells using the Lipofecta-
mine 2000 reagent (Invitrogen, Carlsbad, CA) according to the
manufacturer’s protocol. After an incubation period of 12 h, the
transfection medium was replaced. The cells were harvested after
being exposed to arsenite for 24 h. After three rinses with PBS
(pH 7.4), the cells were lysed with 16passive lysis buffer
(Promega). The cell lysates were analyzed immediately with a
96-well plate luminometer (Berthold Detection System, Pforzheim,
Germany). The amounts of luciferase and Renilla luciferase were
measured with the Dual-Luciferase Reporter Assay System Kit
(Promega) following the manufacturer’s instructions. The values of
luciferase activity for each lysate were normalized to the Renilla
luciferase activity. The relative transcriptional activity was
converted into fold induction above the vehicle control value.
Chromatin immunoprecipitation (ChIP)
ChIP was performed as described Lee at el. [47]. Cells (1610
7)
were treated with or without arsenite for 24 h and cross-linked in
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fragmented to an average size of 500 bp and enriched with
magnetic Dynal bead (Invitrogen)-coupled antibody against HIF-
2a, with no antibody, or with isotype IgG at 4uC overnight. The
cross-links for the enriched and the input DNA were then
reversed, and the DNA was cleaned by RNase A (0.2 mg/ml) and
proteinase K (2 mg/ml) before phenol/chloroform-purification.
The specific sequences from immunoprecipitated and input DNA
were determined by PCR primers for Bmi1 and Twist1 promoters
upstream regions, and their respective control primers not
containing HRE binding elements: Bmi1 promoter forward, 5-
GGCCTCGCCGCCGGCGCG-3, and reverse, 5- CTCCCCT-
CGTGCACTGGGCG-3, the amplicon size was 189 bp; Bmi1
control promoter forward, 5- CGCCGCGGCCTCGGACC -3, and
reverse, 5- GCACGCCCCGGCCTCG -3, the amplicon size was
144 bp; Twist1 promoter forward, 5- TTCCGGCCAGACTGGGGC
-3, and reverse, 5- CTGGCAAAACAGTCGCGG -3, the amplicon
size was 141 bp; Twist1 control promoter forward, 5- TC-
GTCGTCGCCGCCGCCCTC -3, and reverse, 5- GGGTGCGACGG-
GAGCCTG -3, the amplicon size was 147 bp.
Immunostaining
Immunostaining analyses were performed as described previ-
ously [46]. Briefly, HBE cells were stained with rabbit E-cadherin
and vimentin antibody at 4uC overnight and then incubated with
Cy3-conjugated goat-anti-rabbit secondary antibody (Millipore,
Billerica, MA, USA) for 1 h. To stain the nuclei, 49, 6-diamidino-
2-phenylindole (DAPI, Sigma) was added for 10 min, and the cells
were observed under a fluorescence microscope (Olympus,
Shinjuku-ku, Tokyo, Japan). The fluorescence intensities were
measured with a multimode microplate reader (TECAN, Trading,
AG, Switzerland), and images were analyzed with an Image-Pro
Plus 6.0 (Olympus).
Analysis of side populations (SPs)
The HBE cells were removed from the culture dish with trypsin
and EDTA, washed, suspended at 10
6 cells/ml in DMEM/F-12
(Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12;
Gibco-BRL) containing 5% FBS (staining medium), and incubated
in a 1.5-ml Eppendorf tube at 37uC for 10 min. The cells were
then labeled in the same medium at 37uC for 90 min with 5.0 mg/
ml Hoechst 33342 (Sigma) dye, either alone or in combination
with 50 mM verapamil (Sigma), an inhibitor of ATP-binding
cassette (ABC) transporters. The cells were counterstained with
1 mg/ml of propidium iodide (Sigma) to label dead cells. Then,
10
5 cells were passed through a FACSVantage fluorescence-
activated cell sorter (Becton Dickinson, East Rutherford, NJ, USA)
and subjected to dual-wavelength analysis (blue, 424–444 nm; red,
675 nm) after excitation with 350 nm UV light [43].
Spheroid formation
In nonadherent dishes (Costar, US), HBE cells (1610
4) were
suspended in defined, serum-free medium composed of DMEM/
F-12, 10 ng/ml human recombinant basic fibroblast growth factor
(bFGF, R&D Systems) and 10 ng/ml epidermal growth factor
(EGF, R&D Systems). The spheroids were resuspended to form
secondary spheroids. The medium was changed daily along with
growth factor supplementation. For formation of secondary
spheres, dissociated cells of primary spheres were washed at least
three times and then plated on nonadherent plates at the desired
cell densities for an additional 10 days [43].
Statistical analysis
A one-way analysis of variance (ANOVA) was used to assess
differences among groups. Statistical significance was determined
by the Student’s test. P values ,0.05 were considered statistically
significant. Derived values are presented as the means 6 SD.
Supporting Information
Experimental Procedures S1 Anchorage-independent
growth. The method is used in Figure S1.
(DOC)
Experimental Procedures S2 Tumorigenicity in intact
animals. The method is used in Figure S1.
(DOC)
Experimental Procedures S3 Co-immunoprecipitation.
The method is used in Figure S2.
(DOC)
Figure S1 Neoplastic transformation of HBE cells
induced by 1.0 mM arsenite. Abbreviations: HBE, passage
control HBE cells; T-HBE, arsenite-transformed HBE cells; A549,
A549 carcinoma cells. HBE cells were exposed to 0.0 or 1.0 mM
sodium arsenite for about 15 weeks (30 passages). A549 cells served
as a positive control. Cell colonies (A) and their number (B, means
6 SD, n=3) in soft agar; bars=100 mm (Experimental Proce-
dures S1). Cells were injected into nude/BalbC mice. At 4 weeks
after inoculation of the cells. (C) tumors that formed from the
transformed cells and A549 cells were examined and (D) their
volumes were measured (means 6 SD, n=6).
**P,0.01 difference
from medium control cells (Experimental Procedures S2). (E)
Histological examination of the implanted sites of the mice shown
in (C) by haematoxylin and eosin (H&E) stains. Tumors induced
by arsenite-transformed cells were composed of typical undiffer-
entiated squamous epithelium and scar-like tissues; bars=250 mm.
(TIF)
Figure S2 Effects of arsenite on the degradation of HIF-
2a in HBE cells. Densities of bands were quantified by Eagle Eye
II software. GAPDH levels, measured in parallel, served as controls.
HBE cells were exposed to 0.0 and 1.0 mM arsenite for 0, 1, 3, 6, 9,
12, or 24 h, respectively. (A) Western blots of HIF-1a and HIF-2a
were measured after HBE cells were treated by arsenite, or to
100 mM desferroxamine (DFX) for 12 h. The mRNA level of HIF-
2a were determined by RT-PCR (B) and by quantitative PCR (C,
means 6 SD, n=3). After HBE cells were exposed to 1.0 mM
arsenite for 24 h, then such cells were treated with protein synthesis
inhibitor Cycloheximide (CHX, 10 mg/ml) in the absence or
presence of arsenite for the times indicated. Western blot (D)a n d
the levels of protein remaining (E, means 6 SD, n=3) of HIF-2a
were investigated. *P,0.05 and **P,0.01 difference from cells
treated with CHX and arsenite. After HBE cells were treated with
1.0 mM arsenite, 10 mM proteasome inhibitor MG132, or a
combination of these two reagents for 12 h, the levels of HIF-2a
and modfied-HIF-2a, were analysed by Western blot analyses (F).
Cellsweretreatedasdescribedin(F),suchcellsweresubjected toco-
immunoprecipitation with HIF-2a (IP)and ubiquitin(IB) antibodies
(Experimental Procedures S3). Levels of HIF-2a and ubiquitinated-
HIF-2a were determined by Western blot (G).
(TIF)
Table S1 Primers Sequences Used. Primers sequences used
are listed in Table S1.
(DOC)
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